YTHDC2 and acute myeloid leukemia: The results showed that AML patients commonly contain a higher proportion of ALKBH5, CBLL1, FTO, HNRNPA2B1, HNRNPC, IGF2BP1, IGF2BP2, IGF2BP3, METTL14, METTL16, METTL3, RBM15, RBM15B, RBMX, KIAA1429, WTAP, YTHDC1, YTHDC2, YTHDF1, YTHDF2, YTHDF3, ZC3H13, ZNF217 (Figure 2A).